Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Roberts

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Blood Advances|January 4, 2018
Venetoclax: a primerAndrew W Roberts
Journal of General Internal Medicine|May 8, 2020
Naloxone Prescribing Among Frequent Opioid Prescribers in Medicare Part D from 2013 to 2017: a Retrospective StudyAndrew W Roberts
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 2016
Targeting apoptotic pathways to treat lymphoid malignanciesAndrew W Roberts
Growth Factors (Chur, Switzerland)|July 16, 2005
G-CSF: a key regulator of neutrophil production, but that's not all!Andrew W Roberts
Hematology. American Society of Hematology. Education Program|December 4, 2020
Therapeutic development and current uses of BCL-2 inhibitionAndrew W Roberts
Blood|January 1, 2026
Blood: flowing stronger than ever after 80 yearsAndrew W Roberts
Cancer Cell|October 16, 2019
Venetoclax in Lymphoid Malignancies: New Insights, More to LearnRachel Thijssen, Andrew W Roberts
Blood|July 28, 2021
Introduction to a review series on small-molecule targeted therapies for lymphoid malignanciesAndrew W Roberts, Freda K Stevenson
The Medical Journal of Australia|March 3, 2022
Acute leukaemia in Australia: outcomes have improved, but there is still much to doZhi Han Yeoh, Andrew W Roberts
Journal of Managed Care & Specialty Pharmacy|April 26, 2014
Assessing the present state and potential of Medicaid controlled substance lock-in programsAndrew W Roberts, Asheley Cockrell Skinner
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Blood Advances|January 4, 2018
Venetoclax: a primerAndrew W Roberts
Journal of General Internal Medicine|May 8, 2020
Naloxone Prescribing Among Frequent Opioid Prescribers in Medicare Part D from 2013 to 2017: a Retrospective StudyAndrew W Roberts
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 2016
Targeting apoptotic pathways to treat lymphoid malignanciesAndrew W Roberts
Growth Factors (Chur, Switzerland)|July 16, 2005
G-CSF: a key regulator of neutrophil production, but that's not all!Andrew W Roberts
Hematology. American Society of Hematology. Education Program|December 4, 2020
Therapeutic development and current uses of BCL-2 inhibitionAndrew W Roberts
Blood|January 1, 2026
Blood: flowing stronger than ever after 80 yearsAndrew W Roberts
Cancer Cell|October 16, 2019
Venetoclax in Lymphoid Malignancies: New Insights, More to LearnRachel Thijssen, Andrew W Roberts
Blood|July 28, 2021
Introduction to a review series on small-molecule targeted therapies for lymphoid malignanciesAndrew W Roberts, Freda K Stevenson
The Medical Journal of Australia|March 3, 2022
Acute leukaemia in Australia: outcomes have improved, but there is still much to doZhi Han Yeoh, Andrew W Roberts
Journal of Managed Care & Specialty Pharmacy|April 26, 2014
Assessing the present state and potential of Medicaid controlled substance lock-in programsAndrew W Roberts, Asheley Cockrell Skinner
Pageof 20